Technical Outlook And Game Plan For Biomerica Inc (NASDAQ: BMRA)

Biomerica Inc (BMRA) concluded trading on Thursday at a closing price of $0.71, with 393.8 million shares of worth about $279.6 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 91.12% during that period and on January 16, 2025 the price saw a gain of about 101.71%. Currently the company’s common shares owned by public are about 18.34M shares, out of which, 16.17M shares are available for trading.

Stock saw a price change of 115.18% in past 5 days and over the past one month there was a price change of 124.98%. Year-to-date (YTD), BMRA shares are showing a performance of 135.25% which decreased to -26.17% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.24 but also hit the highest price of $1.35 during that period. The average intraday trading volume for Biomerica Inc shares is 943.56K. The stock is currently trading 110.91% above its 20-day simple moving average (SMA20), while that difference is up 108.33% for SMA50 and it goes to 62.33% higher than SMA200.

Biomerica Inc (NASDAQ: BMRA) currently have 18.34M outstanding shares and institutions hold larger chunk of about 8.86% of that.

The stock has a current market capitalization of $12.95M and its 3Y-monthly beta is at -1.05. It has posted earnings per share of -$0.33 in the same period. It has Quick Ratio of 2.22 while making debt-to-equity ratio of 0.12. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BMRA, volatility over the week remained 33.83% while standing at 16.63% over the month.

Analysts are in expectations that Biomerica Inc (BMRA) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Colliers Securities on November 10, 2020 offering a Buy rating for the stock and assigned a target price of $13 to it. Coverage by B. Riley FBR Inc. stated Biomerica Inc (BMRA) stock as a Buy in their note to investors on January 04, 2018, suggesting a price target of $7.50 for the stock.

Most Popular

Related Posts